Previous Close | 0.4900 |
Open | 0.8500 |
Bid | 0.0100 |
Ask | 4.2500 |
Strike | 380.00 |
Expire Date | 2025-01-17 |
Day's Range | 0.4900 - 0.8500 |
Contract Range | N/A |
Volume | |
Open Interest | 113 |
Novo Nordisk stock rose moderately Wednesday after the pharma giant said its new weight-loss drug, amycretin, outperformed Wegovy.
A late-stage clinical trial showed drug helped children aged 6-11 reduce their BMI. It was already approved for children 12 and older.
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AbbVie Inc. (ABBV) and Anheuser-Busch InBev SA/NV (BUD), as well as two micro-cap stocks Servotronics, Inc. (SVT) and United-Guardian, Inc. (UG).